Gene · 3817
Papers1,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-Term SMN- and Ncald-ASO Combinatorial Therapy in SMA Mice and NCALD-ASO Treatment in hiPSC-Derived Motor Neurons Show Protective Effects. | Int J Mol Sci | 2023 | 36835624 | PubTator, text mining | PubMed |
| Molecularly Imprinted Polymers for the Determination of Cancer Biomarkers. | Int J Mol Sci | 2023 | 36835517 | PubTator, text mining | PubMed |
| The Roles of Exosomal Proteins: Classification, Function, and Applications. | Int J Mol Sci | 2023 | 36834471 | PubTator, text mining | PubMed |
| CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. | Cancers (Basel) | 2023 | 36831514 | PubTator, text mining | PubMed |
| mRNA-From COVID-19 Treatment to Cancer Immunotherapy. | Biomedicines | 2023 | 36830845 | PubTator, text mining | PubMed |
| Underlying Features of Prostate Cancer-Statistics, Risk Factors, and Emerging Methods for Its Diagnosis. | Curr Oncol | 2023 | 36826139 | PubTator, text mining | PubMed |
| Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia. | Curr Issues Mol Biol | 2023 | 36826044 | PubTator, text mining | PubMed |
| C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis. | Front Endocrinol (Lausanne) | 2023 | 36817592 | PubTator, text mining | PubMed |
| The Impaired Wound Healing Process Is a Major Factor in Remodeling of the Corneal Epithelium in Adult and Adolescent Patients With Keratoconus. | Invest Ophthalmol Vis Sci | 2023 | 36811882 | PubTator, text mining | PubMed |
| BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1's Interaction with Specific Cellular Pathways. | Int J Mol Sci | 2023 | 36769189 | PubTator, text mining | PubMed |
| Biomarkers of Aggressive Prostate Cancer at Diagnosis. | Int J Mol Sci | 2023 | 36768533 | PubTator, text mining | PubMed |
| Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer. | Cancers (Basel) | 2023 | 36765747 | PubTator, text mining | PubMed |
| Signal-induced enhancer activation requires Ku70 to read topoisomerase1-DNA covalent complexes. | Nat Struct Mol Biol | 2023 | 36747093 | PubTator, text mining | PubMed |
| Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis. | Front Pharmacol | 2023 | 36744249 | PubTator, text mining | PubMed |
| Computational design of custom therapeutic cells to correct failing human cardiomyocytes. | Front Syst Biol | 2023 | 36743445 | PubTator, text mining | PubMed |
| SMAD3 promotes expression and activity of the androgen receptor in prostate cancer. | Nucleic Acids Res | 2023 | 36727462 | PubTator, text mining | PubMed |
| Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAs. | Nano Today | 2023 | 36711067 | PubTator, text mining | PubMed |
| Elevated labile iron in castration-resistant prostate cancer is targetable with ferrous iron-activatable antiandrogen therapy. | Eur J Med Chem | 2023 | 36708680 | PubTator, text mining | PubMed |
| Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators. | Asian J Androl | 2023 | 36695247 | PubTator, text mining | PubMed |
| Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer. | Genes (Basel) | 2023 | 36672877 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3817/papers?page=9